DBV Technologies (DBVT) EBITDA Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121,121.00 |
| Dec 31, 2025 | -576,322.00 |
| Sep 30, 2025 | 115,245.00 |
| Jun 30, 2025 | 90,927.00 |
| Mar 31, 2025 | 196,475.00 |
| Dec 31, 2024 | -276,550.00 |
| Sep 30, 2024 | 44,615.00 |
| Jun 30, 2024 | -77,022.00 |
| Mar 31, 2024 | -210,699.00 |
| Dec 31, 2023 | 81,526.00 |
| Sep 30, 2023 | 19,876.00 |
| Jun 30, 2023 | -29,592.00 |
| Mar 31, 2023 | -222,479.00 |
| Dec 31, 2022 | 302,631.00 |
| Sep 30, 2022 | 66,367.00 |
| Jun 30, 2022 | -150,783.00 |
| Mar 31, 2022 | -17,726.00 |
| Dec 31, 2021 | 154,233.00 |
| Sep 30, 2021 | -22,673.00 |
| Jun 30, 2021 | -56,793.00 |
| Mar 31, 2021 | -372,623.00 |
| Dec 31, 2020 | 285,358.00 |
| Sep 30, 2020 | 73,636.00 |
| Jun 30, 2020 | -17,399.00 |
| Dec 31, 2018 | 195,168.00 |